Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has issued an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its third extraordinary general meeting of 2025, held on 30 December in Guangzhou, was duly convened in compliance with PRC company law and the firm’s articles of association, with most directors and senior management in attendance. All resolutions put to shareholders were passed by poll, with 647 shareholders present on-site or online representing about 53.7% of the company’s issued share capital, signaling broad shareholder participation and support and ensuring the continued corporate actions approved at the meeting carry a strong governance mandate.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$21.00 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a joint stock company incorporated in the People’s Republic of China and listed in Hong Kong via H shares. It operates in the pharmaceutical industry, with its share capital split between A shares on the mainland market and H shares in Hong Kong, giving it access to both domestic and international investors.
Average Trading Volume: 1,253,978
Technical Sentiment Signal: Buy
Current Market Cap: HK$44.35B
Find detailed analytics on 0874 stock on TipRanks’ Stock Analysis page.